Pregled bibliografske jedinice broj: 1045258
Prognostički čimbenici u mijelodisplastičnom sindromu: iskustvo jednog centra
Prognostički čimbenici u mijelodisplastičnom sindromu: iskustvo jednog centra // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 141 (2019), 2; 238-246 doi:10.26800/LV-141-7-8-31 (domaća recenzija, pregledni rad, znanstveni)
CROSBI ID: 1045258 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Prognostički čimbenici u mijelodisplastičnom
sindromu: iskustvo jednog centra
(Prognostic factors in myelodysplastic syndromes:
single-center experience)
Autori
Milunović, Vibor ; Mandac Rogulj, Inga ; Perica, Dražen ; Mišura Jakobac, Karla ; Gredelj-Šimec, Njetočka ; Škrtić, Anita ; Kardum-Skelin, Ika ; Davidović Mrsić, Sanja ; Ostojić Kolonić, Slobodanka
Izvornik
Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora (0024-3477) 141
(2019), 2;
238-246
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Mijelodisplastični sindromi – genetika, klasifikacija, krv, smrtnost ; citogenetska analiza ; međunarodna klasifikacija bolesti ; anemija – komplikacije ; analiza preživljenja ; čimbenici rizika ; prognoza
(Myelodysplatic syndromes – blood, classsification, genetics, mortality ; cytogenetic analysis ; international classification of diseases ; anemia – complications ; survival analysis ; risk factors ; prognosis)
Sažetak
Introduction: Myelodysplastic syndrome (MDS) is one of the most common myeloid neoplasms of elderly characterized by cytopenias and limited therapeutic options. The main aim of this retrospective singlecenter study was to examine the value of classical prognostic factors. The main outcome of the study was overall survival (OS) defined as death from MDS or any other reason. Methods: We analyzed the medical records of patients diagnosed with MDS at single centre in the period from beginning of 2013 to the end of 2016. Results: Total of 58 patients (median age of diagnosis being 69 years) were included in the study. After median of follow-up of 12 months, median OS was 17 months and estimated 3-year OS rate 25%. Classical prognostic systems such as IPSS, WPSS and R-IPSS were statistically significant prognostic factors discriminating adequately between low and high risk groups in terms of outcome. However , due to small sample size, we were not able to distinguish the most appropriate scoring system. The cytogenetics subgroups according to IPPS and R-IPSS were significant predictors of outcomes underlying its crucial role in MDS diagnosis. Despite the statistical tendency morphological features of MDS (2008 World Health Organization subtype and number of blasts in bone marrow) were not significant predictors of OS. Among clinical features, only presence and degree of anemia and transfusion dependency were significant predictors of inferior survival. Conclusion: The majority of traditional prognostic factors were significant in our cohort in concordance with literature review.
Izvorni jezik
Hrvatski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
IP-2016-06-5842 - Prognostička vrijednost i dinamika cirkulirajuće mikroRNA u visokorizičnom mijelodisplastičnom sindromu liječenom 5-azacitidinom (MDSmicroRNA) (Ostojić Kolonić, Slobodanka, HRZZ - 2016-06) ( CroRIS)
Ustanove:
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb,
Akademija medicinskih znanosti
Profili:
Ika Kardum-Skelin
(autor)
Dražen Perica
(autor)
Inga Mandac Smoljanović
(autor)
Njetočka Gredelj Šimec
(autor)
Slobodanka Ostojić Kolonić
(autor)
Anita Škrtić
(autor)
Karla Mišura Jakobac
(autor)
Sanja Davidović-Mrsić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE